Trial Profile
Pivotal phase III trial programme to investigate the effects of oral insulin spray [Ora-lyn] in patients with type 1 diabetes mellitus.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 20 Jun 2011
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Generex Biotechnology Corporation
- 20 Jun 2011 New trial record